Stephen Engelberg was the founding managing editor of ProPublica from 2008–2012, and became editor-in-chief on January 1, 2013. He came to ProPublica from The Oregonian in Portland, where he had been a managing editor since 2002. Before joining The Oregonian, Mr. Engelberg worked for The New York Times for 18 years, including stints in Washington, D.C., and Warsaw, Poland, as well as in New York. He is a member of the Pulitzer Prize Board.
Mr. Engelberg’s work since 1996 has focused largely on the editing of investigative projects. He started the Times’s investigative unit in 2000. Projects he supervised at the Times on Mexican corruption (published in 1997) and the rise of Al Qaeda (published beginning in January 2001) were awarded the Pulitzer Prize. During his years at The Oregonian, the paper won the Pulitzer for breaking news and was a finalist for its investigative work on methamphetamines and charities intended to help the disabled. He is the co-author of “Germs: Biological Weapons and America’s Secret War” (2001).
Unlike many films about reporters, “Spotlight” accurately depicts the frustrations and joys of breaking a big story, from the drudgery of spreadsheets to the electric thrill of revelatory interviews.
A frightened young woman left her apartment in Munich in November 1938 and returned with the visa that saved her family. A team of German journalists launched an improbable search to find the missing artwork and tell its story.
The think tank claims Scorecard’s methods aren’t reliable, but its commentary is undermined by supposition, conflicts of interest and a lack of evidence.
Critics claim our analysis of surgical complications is flawed. We disagree. For the first time, patients can see a surgeon’s record – and use it to help make their best choice.
More than two years ago, a ProPublica series showed that white applicants were far more likely to receive clemency than comparable applicants who were black. Since then, the government has spent hundreds of thousands of dollars on a study, but the pardons system remains unchanged.
Scientists, regulators and manufacturers have come up with numerous proposals
that could reduce the toll of deaths and injuries from one of America’s most
popular drugs.
We explain why publishing this story about U.S. and U.K. government efforts to decode enormous amounts of internet traffic previously thought to have been safe is in the public interest.
The release of Medicare Part D records changes the conversation about how practitioners prescribe drugs -- and indicates the government could do more to ensure they do so safely.
When judges find that prosecutors have abused their authority, other states require them to refer such cases for investigation by disciplinary committees. Should New York follow suit?
The three American companies are cooperating with a Polish investigation into how the companies won lucrative contracts to upgrade Poland’s technology.
Las Vegas Sands' filing with the Securities and Exchange Commission on a possible violation of anti-bribery law leaves unanswered the most fundamental questions about its conduct in Asia.
Join ProPublica’s campaign to shine a light on the hidden aspects of campaign finance by chronicling ad spending in Las Vegas, one of the nation’s most heavily blanketed cities.
The Internal Revenue Service, the Federal Elections Commission and Congress have all played a role in the emergence of undisclosed contributions in the 2012 elections.
Las Vegas Sands has insisted for more than a year that it needed approval from Macau authorities to turn over documents sought by federal investigators and a former employee suing the company for wrongful termination. Now, the company owned by the biggest single Republican donor acknowledges that many of the documents have been in the United States all along.
Thank you for your interest in republishing this story. You are are free to republish it so long as you do the following:
You have to credit ProPublica and any co-reporting partners. In the byline, we prefer “Author Name, Publication(s).” At the top of the text of your story, include a line that reads: “This story was originally published by ProPublica.” You must link the word “ProPublica” to the original URL of the story.
If you’re republishing online, you must link to the URL of this story on propublica.org, include all of the links from our story, including our newsletter sign up language and link, and use our PixelPing tag.
If you use canonical metadata, please use the ProPublica URL. For more information about canonical metadata, refer to this Google SEO link.
You can’t edit our material, except to reflect relative changes in time, location and editorial style. (For example, “yesterday” can be changed to “last week,” and “Portland, Ore.” to “Portland” or “here.”)
You cannot republish our photographs or illustrations without specific permission. Please contact [email protected].
It’s okay to put our stories on pages with ads, but not ads specifically sold against our stories. You can’t state or imply that donations to your organization support ProPublica’s work.
You can’t sell our material separately or syndicate it. This includes publishing or syndicating our work on platforms or apps such as Apple News, Google News, etc.
You can’t republish our material wholesale, or automatically; you need to select stories to be republished individually. (To inquire about syndication or licensing opportunities, contact [email protected].)
You can’t use our work to populate a website designed to improve rankings on search engines or solely to gain revenue from network-based advertisements.
We do not generally permit translation of our stories into another language.
Any website our stories appear on must include a prominent and effective way to contact you.
If you share republished stories on social media, we’d appreciate being tagged in your posts. We have official accounts for ProPublica on Twitter, Facebook and Instagram.
Copy and paste the following into your page to republish:
